Wockhardt Bio AG engages in the research and development, manufacture, and marketing of pharmaceutical products. Its products cover therapeutic categories, including central nervous system agents, hormones and related agents, cardiovascular agents, anti-infective agents, respiratory agents, and other agents such as gastrointestinal, dermatological, and biological agents. The company was founded on October 13, 2005 and is headquartered in Zug, Switzerland.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company